114 related articles for article (PubMed ID: 38551020)
21. Downregulation of miR-3127-5p promotes epithelial-mesenchymal transition via FZD4 regulation of Wnt/β-catenin signaling in non-small-cell lung cancer.
Yang Y; Sun Y; Wu Y; Tang D; Ding X; Xu W; Su B; Gao W
Mol Carcinog; 2018 Jul; 57(7):842-853. PubMed ID: 29566281
[TBL] [Abstract][Full Text] [Related]
22. Curcumin attenuates prostatic hyperplasia caused by inflammation
Liu Y; Wang Z; Gan Y; Chen X; Zhang B; Chen Z; Liu P; Li B; Ru F; He Y
Pharm Biol; 2021 Dec; 59(1):1026-1035. PubMed ID: 34357837
[TBL] [Abstract][Full Text] [Related]
23. Targeting androgen receptor to suppress macrophage-induced EMT and benign prostatic hyperplasia (BPH) development.
Lu T; Lin WJ; Izumi K; Wang X; Xu D; Fang LY; Li L; Jiang Q; Jin J; Chang C
Mol Endocrinol; 2012 Oct; 26(10):1707-15. PubMed ID: 22915828
[TBL] [Abstract][Full Text] [Related]
24. Novel RAS inhibitor 25-O-methylalisol F attenuates epithelial-to-mesenchymal transition and tubulo-interstitial fibrosis by selectively inhibiting TGF-β-mediated Smad3 phosphorylation.
Chen H; Yang T; Wang MC; Chen DQ; Yang Y; Zhao YY
Phytomedicine; 2018 Mar; 42():207-218. PubMed ID: 29655688
[TBL] [Abstract][Full Text] [Related]
25. Iron chelator-induced up-regulation of Ndrg1 inhibits proliferation and EMT process by targeting Wnt/β-catenin pathway in colon cancer cells.
Chen Z; Sun J; Li T; Liu Y; Gao S; Zhi X; Zheng M
Biochem Biophys Res Commun; 2018 Nov; 506(1):114-121. PubMed ID: 30340826
[TBL] [Abstract][Full Text] [Related]
26. GV1001 interacts with androgen receptor to inhibit prostate cell proliferation in benign prostatic hyperplasia by regulating expression of molecules related to epithelial-mesenchymal transition.
Kim Y; Lee D; Jo H; Go C; Yang J; Kang D; Kang JS
Aging (Albany NY); 2021 Feb; 13(3):3202-3217. PubMed ID: 33539321
[TBL] [Abstract][Full Text] [Related]
27. Simvastatin Improves Benign Prostatic Hyperplasia: Role of Peroxisome-Proliferator-Activated Receptor-γ and Classic WNT/β-Catenin Pathway.
Wang Z; Yang S; Li Y; Zhou Y; Liu D; Liu J; DiSanto ME; Zhang X
Int J Mol Sci; 2023 Mar; 24(5):. PubMed ID: 36902342
[TBL] [Abstract][Full Text] [Related]
28. LncRNA DDX11 antisense RNA 1 promotes EMT process of esophageal squamous cell carcinoma by sponging miR-30d-5p to regulate SNAI1/ZEB2 expression and Wnt/β-catenin pathway.
Guo Y; Sun P; Guo W; Yin Q; Han J; Sheng S; Liang J; Dong Z
Bioengineered; 2021 Dec; 12(2):11425-11440. PubMed ID: 34866524
[TBL] [Abstract][Full Text] [Related]
29. Downregulated microRNA-200a promotes EMT and tumor growth through the wnt/β-catenin pathway by targeting the E-cadherin repressors ZEB1/ZEB2 in gastric adenocarcinoma.
Cong N; Du P; Zhang A; Shen F; Su J; Pu P; Wang T; Zjang J; Kang C; Zhang Q
Oncol Rep; 2013 Apr; 29(4):1579-87. PubMed ID: 23381389
[TBL] [Abstract][Full Text] [Related]
30. MiR-19a-3p regulates the Forkhead box F2-mediated Wnt/β-catenin signaling pathway and affects the biological functions of colorectal cancer cells.
Yu FB; Sheng J; Yu JM; Liu JH; Qin XX; Mou B
World J Gastroenterol; 2020 Feb; 26(6):627-644. PubMed ID: 32103872
[TBL] [Abstract][Full Text] [Related]
31. miR-33a suppresses the nuclear translocation of β-catenin to enhance gemcitabine sensitivity in human pancreatic cancer cells.
Liang C; Wang Z; Li YY; Yu BH; Zhang F; Li HY
Tumour Biol; 2015 Dec; 36(12):9395-403. PubMed ID: 26113407
[TBL] [Abstract][Full Text] [Related]
32. MicroRNA-148a suppresses epithelial-mesenchymal transition and invasion of pancreatic cancer cells by targeting Wnt10b and inhibiting the Wnt/β-catenin signaling pathway.
Peng L; Liu Z; Xiao J; Tu Y; Wan Z; Xiong H; Li Y; Xiao W
Oncol Rep; 2017 Jul; 38(1):301-308. PubMed ID: 28586066
[TBL] [Abstract][Full Text] [Related]
33. MiR-122 inhibits epithelial-mesenchymal transition in hepatocellular carcinoma by targeting Snail1 and Snail2 and suppressing WNT/β-cadherin signaling pathway.
Jin Y; Wang J; Han J; Luo D; Sun Z
Exp Cell Res; 2017 Nov; 360(2):210-217. PubMed ID: 28890291
[TBL] [Abstract][Full Text] [Related]
34. Silencing of the lncRNA
Zhang B; Zhao C; Hou L; Wu Y
Am J Physiol Renal Physiol; 2020 Dec; 319(6):F1125-F1134. PubMed ID: 33135476
[TBL] [Abstract][Full Text] [Related]
35. MicroRNA-340 Inhibits Epithelial-Mesenchymal Transition by Impairing ROCK-1-Dependent Wnt/β-Catenin Signaling Pathway in Epithelial Cells from Human Benign Prostatic Hyperplasia.
Chen SY; Du Y; Song J
Chin Med J (Engl); 2018 Aug; 131(16):2008-2012. PubMed ID: 30082536
[No Abstract] [Full Text] [Related]
36. A role for epithelial-mesenchymal transition in the etiology of benign prostatic hyperplasia.
Alonso-Magdalena P; Brössner C; Reiner A; Cheng G; Sugiyama N; Warner M; Gustafsson JA
Proc Natl Acad Sci U S A; 2009 Feb; 106(8):2859-63. PubMed ID: 19196965
[TBL] [Abstract][Full Text] [Related]
37. miR-200b inhibits TGF-β1-induced epithelial-mesenchymal transition and promotes growth of intestinal epithelial cells.
Chen Y; Xiao Y; Ge W; Zhou K; Wen J; Yan W; Wang Y; Wang B; Qu C; Wu J; Xu L; Cai W
Cell Death Dis; 2013 Mar; 4(3):e541. PubMed ID: 23492772
[TBL] [Abstract][Full Text] [Related]
38. MicroRNA-539 functions as a tumour suppressor in prostate cancer via the TGF-β/Smad4 signalling pathway by down-regulating DLX1.
Sun B; Fan Y; Yang A; Liang L; Cao J
J Cell Mol Med; 2019 Sep; 23(9):5934-5948. PubMed ID: 31298493
[TBL] [Abstract][Full Text] [Related]
39. Astragaloside IV suppresses transforming growth factor-β1-induced epithelial-mesenchymal transition through inhibition of Wnt/β-catenin pathway in glioma U251 cells.
Han J; Shen X; Zhang Y; Wang S; Zhou L
Biosci Biotechnol Biochem; 2020 Jul; 84(7):1345-1352. PubMed ID: 32154763
[TBL] [Abstract][Full Text] [Related]
40. Quercetin modulates Wnt signaling components in prostate cancer cell line by inhibiting cell viability, migration, and metastases.
Baruah MM; Khandwekar AP; Sharma N
Tumour Biol; 2016 Oct; 37(10):14025-14034. PubMed ID: 27495232
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]